Advanced Biomed Inc. (ADVB) vs ENDRA Life Sciences Inc. (NDRA)

Advanced Biomed Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $8.9M — 1.2× the size. ENDRA Life Sciences Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Across the 9 metrics below, Advanced Biomed Inc. leads on 7 and ENDRA Life Sciences Inc. on 2.

Valuation

Metric ADVB NDRA Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m 22.35 4.87
P/B 0.91 1.27 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales n/m 7.61 5.66
Earnings yield 74.15% (104.64%) (1.75%)
Free cash flow yield (35.24%) (98.06%) (0.13%)

Profitability

Metric ADVB NDRA Diagnostics & Research median
Gross margin — 0.00% 50.89%
Operating margin 0.00% 0.00% (8.57%)
Net margin 0.00% 0.00% (6.37%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 79.17% (152.04%) (2.92%)
Return on assets 55.78% (110.08%) (6.71%)
Return on invested capital (29.27%) (539.89%) 0.00%

Growth

Metric ADVB NDRA Diagnostics & Research median
Revenue growth (TTM) — — 7.69%
EPS growth (last fiscal year) (15.01%) 84.32% —
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB NDRA Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 7.38 7.10 2.02
Net debt to EBITDA 1.08 0.14 0.78

Dividend

Metric ADVB NDRA Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric ADVB NDRA Diagnostics & Research median
Market cap 10.42m 8.89m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack